MedTrace Logo

Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia

NCT00320723 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2009-05-19

No results posted yet for this study

Summary

This proposal seeks to evaluate a pilot smoking cessation treatment program that will combine nicotine replacement therapy with or without bupropion sustained-release (SR) with cognitive behavioral therapy for smoking cessation in patients with major mental illness.

Conditions

Interventions

DRUG

bupropion, transdermal nicotine patch

Sponsors & Collaborators

  • North Suffolk Mental Health Association

    lead OTHER

Principal Investigators

  • A Eden Evins, MD, MPH · North Suffolk Mental Health Association

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-07-31
Completion
2005-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00320723 on ClinicalTrials.gov